ea0081p117 | Diabetes, Obesity, Metabolism and Nutrition | ECE2022
Kessy Patricia
, Mlawa Gideon
, Ramachandran Kirtanya
, Low Barney
, Hossain Belayet
, Rehmani Hassan
, Saleem Muhammad
, Bell Janessa
Background: Second generation antipsychotics (SGAs) are increasingly playing a bigger role in the treatment of schizophrenia and other psychiatric conditions due to their lower extra pyramidal side effect profile However, SGAs are known to cause clinically relevant metabolic derangements including hyperglycaemiaCase: A 70-year-old gentleman was admitted with generalised weakness and increased urinary frequency (polyuria) and polydipsia. His blood glucose...